GSK Q2 SALES GBP 8,409 MILLION VS. IBES ESTIMATE GBP 8,239 MILLION || Q2 ADJUSTED OPERATING PROFIT GBP 2,800 MILLION VS. IBES ESTIMATE GBP 2
GSK Q2 SALES GBP 8,409 MILLION VS. IBES ESTIMATE GBP 8,239 MILLION || Q2 ADJUSTED OPERATING PROFIT GBP 2,800 MILLION VS. IBES ESTIMATE GBP 2,646 MILLION || Q2 ADJUSTED EPS GBP 0.505 VS. IBES ESTIMATE GBP 0.46 || OUTLOOK FY CORE OPERATING PROFIT GROWTH 7-9%
Story updates
11:02:28 AM UTC
SquawkNews
GSK Q2 SALES GBP 8,409 MILLION VS. IBES ESTIMATE GBP 8,239 MILLION || Q2 ADJUSTED OPERATING PROFIT GBP 2,800 MILLION VS. IBES ESTIMATE GBP 2,646 MILLION || Q2 ADJUSTED EPS GBP 0.505 VS. IBES ESTIMATE GBP 0.46 || OUTLOOK FY CORE OPERATING PROFIT GROWTH 7-9%
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.